Response to Cysteamine in Osteoclasts Obtained from Patients with Nephropathic Cystinosis: A Genotype/Phenotype Correlation
Bone complications of cystinosis have been recently described. The main objectives of this paper were to determine in vitro the impact of CTNS mutations and cysteamine therapy on human osteoclasts and to carry out a genotype-phenotype analysis related to osteoclastic differentiation. Human osteoclas...
Main Authors: | Thomas Quinaux, Aurélia Bertholet-Thomas, Aude Servais, Olivia Boyer, Isabelle Vrillon, Julien Hogan, Sandrine Lemoine, Ségolène Gaillard, Candide Alioli, Sophie Vasseur, Cécile Acquaviva, Olivier Peyruchaud, Irma Machuca-Gayet, Justine Bacchetta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2498 |
Similar Items
-
Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
by: Bouazza Naïm, et al.
Published: (2011-12-01) -
A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis
by: Christina van Stein, et al.
Published: (2021-09-01) -
Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to “A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis”)
by: Craig B. Langman
Published: (2023-06-01) -
Worldwide view of nephropathic cystinosis: results from a survey from 30 countries
by: Aurélia Bertholet-Thomas, et al.
Published: (2017-07-01) -
Importance of adherence to topical cysteamine in infantile ocular cystinosis: An illustrative case
by: Mauricio Bayram-Suverza, et al.
Published: (2022-01-01)